Simplex Trading, LLC Adverum Biotechnologies, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.75 - $1.26 $1,748 - $2,937	2,331 New	2,331 $1,000
Q2 2021 Aug 12, 2021	BUY	$3.36 - $10.56 $83,761 - $263,250	24,929 Added 262.52%	34,425 $120,000
Q1 2021 Apr 26, 2021	BUY	$9.26 - $14.36 $40,669 - $63,069	4,392 Added 86.05%	9,496 $93,000
Q4 2020 Feb 02, 2021	SELL	$9.84 - $14.26 $215,751 - $312,664	-21,926 Reduced 81.12%	5,104 $55,000
Q3 2020 Oct 14, 2020	SELL	$10.3 - $21.64 $599,315 - $1.26 Million	-58,186 Reduced 68.28%	27,030 $278,000
Q2 2020 Jul 13, 2020	BUY	$8.53 - $25.64 $622,007 - $1.87 Million	72,920 Added 593.04%	85,216 $1.78 Million
Q1 2020 Apr 29, 2020	SELL	$7.98 - $16.32 $224,740 - $459,620	-28,163 Reduced 69.61%	12,296 $120,000
Q4 2019 Feb 05, 2020	BUY	$5.12 - $12.22 $207,150 - $494,408	40,459 New	40,459 $466,000
Q3 2019 Oct 15, 2019	SELL	$5.24 - $15.89 $111,606 - $338,441	-21,299 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$5.1 - $11.89 $101,112 - $235,731	19,826 Added 1345.96%	21,299 $253,000
Q1 2019 Apr 18, 2019	SELL	$3.03 - $6.02 $14,301 - $28,414	-4,720 Reduced 76.22%	1,473 $0
Q4 2018 Jan 16, 2019	BUY	$2.87 - $5.92 $918 - $1,894	320 Added 5.45%	6,193 $19,000
Q3 2018 Oct 23, 2018	BUY	$4.5 - $7.6 $26,428 - $44,634	5,873 New	5,873 $35,000
Q2 2018 Jul 30, 2018	SELL	$5.3 - $6.9 $211,639 - $275,530	-39,932 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$3.65 - $7.95 $40,226 - $87,616	11,021 Added 38.12%	39,932 $231,000
Q4 2017 Jan 10, 2018	BUY	$2.85 - $3.95 $37,423 - $51,867	13,131 Added 83.21%	28,911 $101,000
Q3 2017 Oct 25, 2017	BUY	$2.45 - $3.65 $38,661 - $57,597	15,780	15,780 $57,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account